Your browser doesn't support javascript.
loading
Corrigendum to "Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation": [Annals of Oncology 28 (2017):2503-2510].
Takamatsu, H; Takezako, N; Zheng, J; Moorhead, M; Carlton, V E H; Kong, K A; Murata, R; Ito, S; Miyamoto, T; Yokoyama, K; Matsue, K; Sato, T; Kurokawa, T; Yagi, H; Terasaki, Y; Ohata, K; Matsumoto, M; Yoshida, T; Faham, M; Nakao, S.
Afiliación
  • Takamatsu H; Hematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan. Electronic address: takamaz@staff.kanazawa-u.ac.jp.
  • Takezako N; Department of Hematology, National Hospital Organization Disaster Medical Center of Japan, Tachikawa, Japan.
  • Zheng J; Adaptive Biotechnologies Corp., South San Francisco, USA.
  • Moorhead M; Adaptive Biotechnologies Corp., South San Francisco, USA.
  • Carlton VEH; Adaptive Biotechnologies Corp., South San Francisco, USA.
  • Kong KA; Adaptive Biotechnologies Corp., South San Francisco, USA.
  • Murata R; Division of Internal Medicine, Keiju Kanazawa Hospital, Kanazawa, Japan.
  • Ito S; Department of Medical Oncology, Iwate Medical University School of Medicine, Morioka, Japan.
  • Miyamoto T; Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Yokoyama K; Department of Hematology/Oncology, Tokai University Hachioji Hospital, Hachioji, Japan.
  • Matsue K; Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, Japan.
  • Sato T; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kurokawa T; Department of Hematology, Toyama Red Cross Hospital, Toyama, Japan.
  • Yagi H; Department of Hematology, Kinki University School of Medicine Nara Hospital, Ikoma, Nara, Japan.
  • Terasaki Y; Division of Internal Medicine, Toyama City Hospital, Toyama, Japan.
  • Ohata K; Hematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Matsumoto M; Department of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan.
  • Yoshida T; Department of Hematology, Shizuoka City Shimizu Hospital, Shizuoka, Japan.
  • Faham M; Adaptive Biotechnologies Corp., South San Francisco, USA.
  • Nakao S; Hematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Ann Oncol ; 34(3): 322, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36075840
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article